Sutro Biopharma (STRO) — Net Asset Momentum
Sutro Biopharma (STRO) recorded a net asset momentum of -70.2% as of December 2024, with net assets of $44.60 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See STRO defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Sutro Biopharma Net Asset Momentum (2016–2024)
This chart tracks Sutro Biopharma's year-over-year net asset growth across 9 annual reporting periods from 2016 to 2024. The most recent momentum reading is -70.2%, with net assets of $44.60 Million USD as of December 2024. Read debt load of Sutro Biopharma for a breakdown of total debt and financial obligations.
Annual Net Asset History for Sutro Biopharma (2016–2024)
The table below shows the complete annual net asset history for Sutro Biopharma from 2016 to 2024, covering 9 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see how much is Sutro Biopharma worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $44.60 Million | $387.21 Million | $342.61 Million | ▼ -70.2% |
| 2023 | $149.65 Million | $470.74 Million | $321.09 Million | ▼ -31.1% |
| 2022 | $217.05 Million | $406.94 Million | $189.90 Million | ▼ -14.1% |
| 2021 | $252.56 Million | $341.41 Million | $88.84 Million | ▼ -23.9% |
| 2020 | $332.05 Million | $394.11 Million | $62.06 Million | ▲ +239.6% |
| 2019 | $97.79 Million | $156.37 Million | $58.58 Million | ▼ -25.7% |
| 2018 | $131.54 Million | $223.14 Million | $91.60 Million | ▲ +220.7% |
| 2017 | $-109.00 Million | $40.77 Million | $149.77 Million | ▼ -19.9% |
| 2016 | $-90.90 Million | $69.28 Million | $160.18 Million | — |